Page last updated: 2024-08-24

2,4,6-trihydroxybenzaldehyde and Colonic Neoplasms

2,4,6-trihydroxybenzaldehyde has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choy, YY; Forester, SC; Oteiza, PI; Waterhouse, AL1

Other Studies

1 other study(ies) available for 2,4,6-trihydroxybenzaldehyde and Colonic Neoplasms

ArticleYear
The anthocyanin metabolites gallic acid, 3-O-methylgallic acid, and 2,4,6-trihydroxybenzaldehyde decrease human colon cancer cell viability by regulating pro-oncogenic signals.
    Molecular carcinogenesis, 2014, Volume: 53, Issue:6

    Topics: Anthocyanins; Apoptosis; Benzaldehydes; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Colonic Neoplasms; Dose-Response Relationship, Drug; Gallic Acid; Humans; NF-kappa B; Organic Cation Transporter 1; Signal Transduction; STAT1 Transcription Factor; Transcription Factor AP-1

2014